Webinar: US FOLLOW ON BIOLOGICS MARKET: DEVELOPMENTS, TRENDS AND STRATEGIES

Presented by

ANDREW F BOURGOIN,

Pharmaceutical Research Analyst Thomson Reuters

Andrew F Bourgoin is a Pharmaceutical Research Analyst at Thomson Reuters. In addition to collecting and validating intelligence contained in the Newport product suite, Andrew actively tracks developments within the global biologic pharmaceutical landscape. Prior to joining Thomson Reuters, Andrew was a graduate student at the Muskie School for Public Service where he received a master degree in public policy and management.

PHIL MILLER,

Director of Product Strategy Thomson Reuters

Phil Miller, holds a M.Chem in Chemistry from the University of Oxford. He started his career as a chemistry lecturer at a further education college, where he spent a number of years teaching chemistry and science in general. He subsequently joined Evotec as a drug discovery scientist working on a wide variety of projects from lead discovery to preclinical development before becoming a team leader and subsequently a project manager. Phil worked at CMR prior to moving to IMS Health for two years managing the Global Data Production team. Phil returned to CMR as Director of Product Strategy with responsibility for the CMR portfolio of programmes and services.